Tripterygium Glycosides Extract-Induced Hepatic Cholestasis: A Mechanistic Study Using a Microfluidic Liver-on-a-Chip System
International Journal of Molecular Sciences · 06.05.2026 · 27 (9) · 4154
DOI: 10.3390/ijms27094154 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.05.2026. Verfasst von Yifei Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, State Key Laboratory for Quality Ensurance and Sustainable Use of Dao…. Hauptthemen laut MEDLINE: Tripterygium, Glycosides, Liver, Plant Extracts. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
Tripterygium glycosides extract (TGE), the primary active component of tripterygium glycosides tablets, is widely used for immune-related disorders but raises significant clinical concerns regarding cholestatic drug-induced liver injury. As conventional models fail to fully recapitulate the complex pathogenesis of traditional Chinese medicine toxicity, this study aimed to elucidate the mechanisms of TGE-induced cholestatic injury using a biomimetic microfluidic liver-on-a-chip platform. The chip integrated rat precision-cut liver slices (PCLSs) and human endothelial cells (EA.hy926) to simulate the hepatic sinusoidal microenvironment. Following TGE exposure (15–135 μg/mL for 12 and 24 h), vascular barrier integrity was maintained, while liver injury markers (ALT, AST, TBA, DBIL) significantly increased in a dose- and time-dependent manner, accompanied by progressive histopathological deterioration in PCLSs. Mechanistically, TGE triggered severe oxidative stress (decreased SOD/GSH/GSH-Px and increased MDA) and upregulated pro-inflammatory cytokines (IL-4 and IL-1β). Consequently, the expression of the bile acid receptor FXR and transporters (BSEP and MRP2) was significantly downregulated. In conclusion, TGE induces cholestatic liver injury via a sequential pathway: oxidative stress initiates an immune-inflammatory response, which subsequently suppresses the FXR/BSEP/MRP2 axis. Future studies should focus on developing fully humanized liver-on-a-chip systems to further validate these mechanisms and improve clinical translational significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Beijing 100700, China.
Förderung
- National Natural Science Foundation of China
- Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences
Zitieren
APA
Yang, Y., Zhang, Y., Yang, Y., Xia, B., Zhang, H., Zhang, G., Gong, P., Qi, Y., Wu, Z., Li, C., & Liu, T. (2026). Tripterygium Glycosides Extract-Induced Hepatic Cholestasis: A Mechanistic Study Using a Microfluidic Liver-on-a-Chip System. International Journal of Molecular Sciences, 27(9), 4154. https://doi.org/10.3390/ijms27094154
Vancouver
Yang Y, Zhang Y, Yang Y, Xia B, Zhang H, Zhang G, et al. Tripterygium Glycosides Extract-Induced Hepatic Cholestasis: A Mechanistic Study Using a Microfluidic Liver-on-a-Chip System. International Journal of Molecular Sciences. 2026;27(9):4154. doi:10.3390/ijms27094154
BibTeX
@article{Yang2026,
author = {Yang, Yifei and Zhang, Ya and Yang, Yun and Xia, Bing and Zhang, Haijing and Zhang, Guozhuang and Gong, Ping and Qi, Ying and Wu, Zhe and Li, Chun and Liu, Ting},
title = {Tripterygium Glycosides Extract-Induced Hepatic Cholestasis: A Mechanistic Study Using a Microfluidic Liver-on-a-Chip System},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {4154},
doi = {10.3390/ijms27094154}
}
EUVIMED